Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

52.2K
Overview
52.2K
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

319
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
319
Physiological Barriers01:25

Physiological Barriers

5.0K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
5.0K
Passive Diffusion: Overview and Kinetics01:17

Passive Diffusion: Overview and Kinetics

1.2K
Passive diffusion is a critical process that allows small lipophilic drugs to cross the cell membrane along a concentration gradient. This mechanism's efficiency depends on four primary factors: the membrane's surface area, the drug's lipid-water partition coefficient, the concentration gradient, and the membrane's thickness.
When administered orally, drugs establish a substantial concentration gradient between the gastrointestinal (GI) lumen and the bloodstream, expediting...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dead-Space Microdomains as Explicit Barriers to Extracellular Drug Transport in Alzheimer's Disease.

Pharmaceutical research·2026
Same author

Exploring Bevacizumab's Role in Gynecological Cancers: An Up-to-Date Narrative Review Focusing on Ovarian Cancer.

Materia socio-medica·2025
Same author

Mathematical Study of the Perturbation of Magnetic Fields Caused by Erythrocytes.

Advances in experimental medicine and biology·2023
Same author

Qualitative Differences Between the Semi-separable and the "Almansi-Type" Stokes Stream Function Expansions in the Study of Biological Fluids.

Advances in experimental medicine and biology·2022
Same author

A Multiscale Mathematical Model for Tumor Growth, Incorporating the GLUT1 Expression.

Advances in experimental medicine and biology·2022
Same author

In Reply.

The oncologist·2020
Same journal

Peptidomics in the Spotlight: Advanced Sample Treatment Techniques and Analytical Insights.

Advances in experimental medicine and biology·2026
Same journal

Methods for the Investigation of Protein-Ligands Interactions.

Advances in experimental medicine and biology·2026
Same journal

Sample Preparation Strategies for Microbial Cell Surface Proteomics: Integrating Shaving and Shotgun Approaches.

Advances in experimental medicine and biology·2026
Same journal

Proteomic Sample Preparation for the Petroleum Industry: A Biocorrosion Case Study.

Advances in experimental medicine and biology·2026
Same journal

Proteomic and Functional Comparison of Extracellular Vesicles from Wild-Type and Lyn-Deficient Stromal Cells.

Advances in experimental medicine and biology·2026
Same journal

Proteomic Analysis of Histone Sequence Variants and Post-translationally Modified Forms.

Advances in experimental medicine and biology·2026
See all related articles

Related Experiment Video

Updated: Jan 10, 2026

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain
07:52

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain

Published on: April 9, 2019

9.1K

Towards Precise Modelling of Diffusion Across the Blood-Brain Barrier.

Dimitrios Charemis1, Gregory Sivolapenko2, Maria Hadjinicolaou3

  • 1School of Science and Technology, Hellenic Open University, Patras, Greece. charemis.dimitris@ac.eap.gr.

Advances in Experimental Medicine and Biology
|November 22, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a new physiological model using partial differential equations (PDEs) to simulate passive solute transport across the blood-brain barrier (BBB). The model accurately predicts spatial and temporal solute concentrations, aiding neurological drug development.

Keywords:
Blood-brain barrier (BBB)Drug targetingPartial differential equations (PDEs)Passive diffusionTransport modelling

More Related Videos

Setting-up an In Vitro Model of Rat Blood-brain Barrier BBB: A Focus on BBB Impermeability and Receptor-mediated Transport
16:26

Setting-up an In Vitro Model of Rat Blood-brain Barrier BBB: A Focus on BBB Impermeability and Receptor-mediated Transport

Published on: June 28, 2014

43.2K
Author Spotlight: Advancing the Use of Tissue Chip Technology for Studying Human Tissues
09:10

Author Spotlight: Advancing the Use of Tissue Chip Technology for Studying Human Tissues

Published on: January 12, 2024

3.6K

Related Experiment Videos

Last Updated: Jan 10, 2026

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain
07:52

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain

Published on: April 9, 2019

9.1K
Setting-up an In Vitro Model of Rat Blood-brain Barrier BBB: A Focus on BBB Impermeability and Receptor-mediated Transport
16:26

Setting-up an In Vitro Model of Rat Blood-brain Barrier BBB: A Focus on BBB Impermeability and Receptor-mediated Transport

Published on: June 28, 2014

43.2K
Author Spotlight: Advancing the Use of Tissue Chip Technology for Studying Human Tissues
09:10

Author Spotlight: Advancing the Use of Tissue Chip Technology for Studying Human Tissues

Published on: January 12, 2024

3.6K

Area of Science:

  • Pharmacokinetics and Drug Delivery
  • Biophysics and Mathematical Modeling
  • Neuroscience and Neurology

Background:

  • The blood-brain barrier (BBB) presents a significant challenge for drug delivery to the central nervous system.
  • Existing models for passive diffusion across the BBB often lack integration of biophysical principles into comprehensive differential equations.
  • Accurate modeling of solute transport is crucial for developing targeted therapies for neurological disorders.

Purpose of the Study:

  • To develop and validate a physiological model for passive solute fluxes across the BBB using parabolic partial differential equations (PDEs).
  • To compare the predictive capabilities of the PDE model against existing compartmental ordinary differential equation (ODE) models.
  • To highlight the computational advantages of the PDE approach for pharmaceutical targeting in neurological conditions.

Main Methods:

  • Quantified physiological parameters at BBB transport interfaces.
  • Developed a PDE model incorporating biophysical principles and solute properties.
  • Obtained analytical and numerical solutions to the PDE system with characteristic initial and boundary conditions.
  • Performed PDE stability analysis.
  • Compared the PDE model's temporal and spatial predictions with a compartmental ODE model using mannitol and sucrose.

Main Results:

  • Demonstrated convergence of temporal concentration values for mannitol and sucrose between the PDE and ODE models.
  • Showcased the superior ability of the PDE model in predicting spatial solute concentration gradients.
  • Validated the accuracy and utility of the PDE model through stability analysis.

Conclusions:

  • The proposed PDE model offers significant computational advantages for studying passive diffusion across the BBB.
  • This model can be extended to multi-dimensional, steady, and unsteady state simulations.
  • The model's direct incorporation of physiological and pharmaceutical parameters provides accurate spatial and temporal predictions, beneficial for neurological drug development.